Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 24.10.2024
Aareal Bank AG
EQS-Media / 24.10.2024 / 10:00 CET/CEST
Aareal Bank and Henderson Park strengthen partnership through £275 million financing of Edinburgh and Dublin hotel portfolio
Wiesbaden, 24 October 2024 – Henderson Park and Aareal Bank are pleased to announce they have signed a c. £275 million financing loan secured against three hotels: the Curio Colle [ … ]
Thu, 24.10.2024
Aareal Bank AG
EQS-Media / 24.10.2024 / 10:00 CET/CEST
Aareal Bank and Henderson Park strengthen partnership through £275 million financing of Edinburgh and Dublin hotel portfolio
Wiesbaden, 24 October 2024 – Henderson Park and Aareal Bank are pleased to announce they have signed a c. £275 million financing loan secured against three hotels: the Curio Colle [ … ]
Thu, 24.10.2024
Aareal Bank AG
EQS-Media / 24.10.2024 / 10:00 CET/CEST
Aareal Bank and Henderson Park strengthen partnership through £275 million financing of Edinburgh and Dublin hotel portfolio
Wiesbaden, 24 October 2024 – Henderson Park and Aareal Bank are pleased to announce they have signed a c. £275 million financing loan secured against three hotels: the Curio Colle [ … ]
Thu, 24.10.2024
QUANTRO Therapeutics GmbH
QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery
Strategic partnership with the Research Institute of Molecular Pathology (IMP) to decipher transcription factor complexes
QUANTRO CEO Dr. Michael Bauer to attend BIO-Europe in Stockholm, November 4-6
Vienna, Austria, 24 October 2024: QUANTRO [ … ]
Thu, 24.10.2024
QUANTRO Therapeutics GmbH
QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery
Strategic partnership with the Research Institute of Molecular Pathology (IMP) to decipher transcription factor complexes
QUANTRO CEO Dr. Michael Bauer to attend BIO-Europe in Stockholm, November 4-6
Vienna, Austria, 24 October 2024: QUANTRO [ … ]
Thu, 24.10.2024
QUANTRO Therapeutics GmbH
QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery
Strategic partnership with the Research Institute of Molecular Pathology (IMP) to decipher transcription factor complexes
QUANTRO CEO Dr. Michael Bauer to attend BIO-Europe in Stockholm, November 4-6
Vienna, Austria, 24 October 2024: QUANTRO [ … ]
Thu, 24.10.2024
Zentiva AG
APONTIS PHARMA shareholders can tender their shares from today – Offer Document published
Voluntary public purchase offer for APONTIS PHARMA starts today – Offer Document published
Acceptance period expected to expire on 21 November 2024 at 24:00 (CET)
Offer price of EUR 10.00 in cash represents a premium of 52.9% over the closing share pri [ … ]
Thu, 24.10.2024
Zentiva AG
APONTIS PHARMA shareholders can tender their shares from today – Offer Document published
Voluntary public purchase offer for APONTIS PHARMA starts today – Offer Document published
Acceptance period expected to expire on 21 November 2024 at 24:00 (CET)
Offer price of EUR 10.00 in cash represents a premium of 52.9% over the closing share pri [ … ]
Thu, 24.10.2024
Zentiva AG
APONTIS PHARMA shareholders can tender their shares from today – Offer Document published
Voluntary public purchase offer for APONTIS PHARMA starts today – Offer Document published
Acceptance period expected to expire on 21 November 2024 at 24:00 (CET)
Offer price of EUR 10.00 in cash represents a premium of 52.9% over the closing share pri [ … ]
Thu, 24.10.2024
Cherry SE
Munich, 24 October 2024 - Cherry SE today announces preliminary financial performance indicators for the third quarter and the first nine months of 2024. Key aspects of the recently updated forecast for the 2024 financial year are also explained. Both the high proportion of business in Germany and the structural problems in the Gaming & Office [ … ]